Evidence map›Paper›PMID 38793970›Full record

ArticleSensors (Basel, Switzerland)2024

Optimization of Surface Functionalizations for Ring Resonator-Based Biosensors.

Niccolò Ardoino, Lorenzo Lunelli, Georg Pucker, Lia Vanzetti, Rachele Favaretto, Laura Pasquardini, Cecilia Pederzolli, Carlo Guardiani, Cristina Potrich

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Optical Biosensors and Applications.Sensors (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Niccolò ArdoinoFTH S.r.l., Via Sommarive 18, I-38123 Trento, Italy.ORCID 0009-0007-4837-254X
Lorenzo LunelliCenter for Sensors & Devices, Fondazione Bruno Kessler, Via Sommarive 18, I-38123 Trento, Italy.ORCID 0000-0002-8824-2084
Georg PuckerCenter for Sensors & Devices, Fondazione Bruno Kessler, Via Sommarive 18, I-38123 Trento, Italy.ORCID 0000-0002-9338-8686
Lia VanzettiCenter for Sensors & Devices, Fondazione Bruno Kessler, Via Sommarive 18, I-38123 Trento, Italy.ORCID 0000-0001-8306-8390
Rachele FavarettoFTH S.r.l., Via Sommarive 18, I-38123 Trento, Italy.ORCID 0009-0006-8200-9958
Laura PasquardiniIndivenire S.r.l., Via Sommarive 18, I-38123 Trento, Italy.ORCID 0000-0001-9171-7856
Cecilia PederzolliCenter for Sensors & Devices, Fondazione Bruno Kessler, Via Sommarive 18, I-38123 Trento, Italy.ORCID 0000-0002-3449-7874
Carlo GuardianiFTH S.r.l., Via Sommarive 18, I-38123 Trento, Italy.ORCID 0009-0007-6134-4332
Cristina PotrichCenter for Sensors & Devices, Fondazione Bruno Kessler, Via Sommarive 18, I-38123 Trento, Italy.ORCID 0000-0002-0793-7547

Funding

Autonomous Province of Trento (Italy) SUPREMO project (LP 6/99, 018-19 of 07.11.2019)
6 · The paper itself

Abstract

Liquid biopsy is expected to become widespread in the coming years thanks to point of care devices, which can include label-free biosensors. The surface functionalization of biosensors is a crucial aspect that influences their overall performance, resulting in the accurate, sensitive, and specific detection of target molecules. Here, the surface of a microring resonator (MRR)-based biosensor was functionalized for the detection of protein biomarkers. Among the several existing functionalization methods, a strategy based on aptamers and mercaptosilanes was selected as the most highly performing approach. All steps of the functionalization protocol were carefully characterized and optimized to obtain a suitable protocol to be transferred to the final biosensor. The functionalization protocol comprised a preliminary plasma treatment aimed at cleaning and activating the surface for the subsequent silanization step. Different plasma treatments as well as different silanes were tested in order to covalently bind aptamers specific to different biomarker targets, i.e., C-reactive protein, SARS-CoV-2 spike protein, and thrombin. Argon plasma and 1%

Indexed as

Aptamers, NucleotideBiosensing TechniquesSilanesThrombinBiomarkersCOVID-19C-Reactive ProteinHumansSARS-CoV-2Spike Glycoprotein, CoronavirusSurface PropertiesAptamers, NucleotideBiomarkersC-Reactive ProteinSilanesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Thrombinaptamer functionalizationbiomarker detectionon-chip liquid biopsyphotonic biosensorsurface silanization

Identifiers

PMID38793970
PMCPMC11124806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.